This transaction is consistent with Simcere’s strategy to focus on first-to-market and innovative new drugs and expand its anticancer product portfolio.
This transaction is consistent with Simcere’s strategy to focus on first-to-market and innovative new drugs and expand its anticancer product portfolio.